Understanding ARBs: Angiotensin Receptor Blockers for Blood Pressure & Heart Failure

ARBs (Angiotensin II Receptor Blockers) block the AT₁ receptor, preventing angiotensin II–mediated vasoconstriction, aldosterone release, sodium retention, and remodeling.

Common Agents

  • Losartan (prototype), Valsartan, Irbesartan, Olmesartan, Telmisartan, Candesartan, Azilsartan.

Indications

  • Hypertension (first-line, especially in diabetes/CKD).
  • Heart failure with reduced EF (HFrEF) – alternative to ACEi.
  • Post-MI LV dysfunction.
  • Diabetic nephropathy (renoprotection).
  • Stroke prevention (Losartan in LIFE trial).

Advantages over ACE Inhibitors

  • No bradykinin accumulation → no cough (major tolerability advantage).
  • Lower angioedema risk.
  • Once-daily dosing (most).

Monitoring

  • K⁺, Cr (baseline, 1–2 wks, periodically) – hyperkalemia, AKI risk.
  • BP, volume status.
  • Contraindicated in pregnancy (fetotoxicity).

ARBs are cornerstone RAAS blockade therapy with favorable side-effect profile.

Medical Billing - Related Articles